Researchers at University of California San Diego School of Medicine discovered that they can block inflammation in mice with a naturally occurring antibody that binds oxidized phospholipids (OxPL), molecules on cell surfaces that get modified by inflammation. Even while on a high-fat diet, the antibody protected the mice from arterial plaque formation, hardening of the arteries and liver disease, and prolonged their lives.
This study, published June 6 by Nature, marks the first demonstration in a living system that OxPL triggers inflammation and leads to plaque formation. The results also suggest a new approach for preventing or reversing a number of inflammatory diseases.
“Wherever you get inflammation, you get OxPL,” said senior author Joseph Witztum, MD, professor of medicine at UC San Diego School of Medicine. “It doesn’t mean OxPL is the cause, but it definitely plays a major role.” Witztum led the study with first author Xuchu Que, PhD, a senior project scientist at UC San Diego School of Medicine.
Some phospholipids — the molecules that make up cell membranes — are prone to modification by reactive oxygen species, forming OxPL. This event is particularly common in inflammatory conditions such as atherosclerosis, in which artery-blocking plaques form. Prior to this study, researchers were unable to control phospholipid oxidation in a way that would allow them to study its role in inflammation and atherosclerosis.
Witztum, Que and team engineered mice with two special attributes: 1) they have a gene mutation that makes them a good model for atherosclerosis and 2) they generate a piece of an antibody called E06 that’s just enough to bind OxPL and prevent their ability to cause inflammation in immune cells, but not enough to cause inflammation on its own. They fed the mice a high-fat diet.
Here’s what happened: Compared to control mice, the mice with E06 antibodies had 28 to 57 percent less atherosclerosis, even after one year and despite having high levels of cholesterol. The antibody also decreased aortic valve calcification (hardening and narrowing of the aortic valves), hepatic steatosis (fatty liver disease) and liver inflammation. E06 antibody-producing mice had 32 percent less serum amyloid A, a marker of systemic inflammation.
The E06 antibody also prolonged the life of the mice. After 15 months, all of the E06 antibody-producing mice were alive, compared to 54 percent of the control mice.
“We showed for the first time that OxPL are truly pro-inflammatory and pro-atherogenic and, moreover, that they can be counteracted by E06 antibody,” Witztum said. “This suggests that therapies that inactivate OxPL may be beneficial for reducing inflammation in general, and in particular in the case of diseases such as atherosclerosis, aortic stenosis and hepatic steatosis.”
Witztum and team are now testing E06 antibody in mouse models of human diseases linked to inflammation, such as osteoporosis (bone loss) and nonalcoholic steatohepatitis (NASH, a type of liver disease).
The Latest on: Inflammation
via Google News
The Latest on: Inflammation
- Plonk yourself down in the 'world's first' mulled wine hot tub, which it's claimed is 'ideal for reducing inflammation'on November 26, 2020 at 3:45 am
A soak in the tub will be offered from next month in an experience called the Mulled Wine Spa Day at Shrigley Hall in Cheshire. The festive drink will be heated to a cosy 37 degrees.
- Why Your Iron and Inflammation Levels Surge After You Run a Marathonon November 25, 2020 at 6:54 am
Your iron and inflammation levels surge after long-distance efforts—here’s how to get them back to normal faster.
- Regenerative drug summons stem cells for inflammation-free healingon November 24, 2020 at 6:17 pm
Researchers have developed a drug that can mimic inflammation signals to lure stem cells to damaged tissue, without causing any further inflammation. The technique could be a boon for regenerative ...
- 'Dramatic' Inflammation Reduction After OHCA With Tocilizumabon November 24, 2020 at 10:46 am
A pilot study showed reduced systemic inflammatory response and cardiac injury in out-of-hospital cardiac arrest patients, with the hope of affecting mortality and neurologic outcome in larger trials.
- Gut-Brain Axis Influences Inflammation in Multiple Sclerosison November 23, 2020 at 9:14 pm
A research team has discovered a connection between the intestinal flora and sites of inflammation in the central nervous system in multiple sclerosis. A specific class of immune cell plays a central ...
- Support Healthy Inflammation for Glowing Healthon November 20, 2020 at 12:59 pm
We need healthy inflammation to protect and heal the body, but chronic inflammation can cause pain, fatigue, and multiple adverse health effects that can lead to disease. Discover some easy ways to ...
- COVID-19 during pregnancy can cause placental inflammation and impaired immunityon November 19, 2020 at 6:09 pm
A new study conducted by a team of researchers at Johns Hopkins University, USA, has observed how pregnant women infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) show stunted ...
- Scientists discover potential strategy to prevent inflammation in COVID-19 patientson November 19, 2020 at 9:17 am
The COVID-19 pandemic continues to cause significant illness and death while treatment options remain limited. St. Jude Children's Research Hospital scientists have discovered a potential strategy to ...
- New Book From Nationally Known Dietitian, Jan Tilley, Offers Readers A Path To Reversing Chronic Inflammationon November 17, 2020 at 10:28 am
Tilley, a nationally recognized dietitian specializing in chronic disease management, has just released a third book dedicated to helping those suffering with chronic inflammation. The book is ...
via Bing News